FIELD: medicine.
SUBSTANCE: for the purpose of treating allergy in an individual characterised by cytokine Th1 and Th2 imbalance, β-hydroxy-β-methylbutyrate (HMB) is introduced into the individual in an amount effective to reduce cytokine Th1 and Th2 production imbalance. What is also presented is a method of treating allergy in the individual belonging to a risk group of developing allergy.
EFFECT: elimination, delay and reduction of the rate of the onset or severity of allergy-related symptoms due to increase of the cytokine Th1 content with no increase of the cytokine Th2 content.
11 cl, 5 dwg, 8 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF TREATING ALLERGIC DISEASES | 2011 |
|
RU2587061C2 |
| EDIBLE COMPOSITION CONTAINING STRAINS LACTOCOCCUS AND REDUCING ALLERGY SYMPTOMS, PARTICULARLY IN INFANTS AND CHILDREN | 2010 |
|
RU2575072C2 |
| IMMUNOMODULATING OLIGOSACCHARIDE | 2004 |
|
RU2388478C2 |
| SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES | 2005 |
|
RU2393223C2 |
| APPLICATION OF MYCOBACTERIUM VACCAE FOR FEEDBACK INHIBITION REGULATION OF TH2-ACTIVITY OF IMMUNE SYSTEM | 1997 |
|
RU2197989C2 |
| COMPOSITIONS TO TREAT INFLAMMATORY BOWEL CONDITION | 2008 |
|
RU2495121C2 |
| USE OF LGG FOR PREVENTION OR TREATMENT OF RESPIRATORY ALLERGIES | 2006 |
|
RU2435598C2 |
| MEDICATION, CONTAINING FGF2 AS ACTIVE INGREDIENT, FOR TREATMENT OR PREVENTION OF ASTHMA AND CHRONIC OBSTRUCTIVE LUNG DISEASES | 2005 |
|
RU2351356C2 |
| METHOD OF TREATING CHRONIC RHINOSINUSITIS | 2011 |
|
RU2469737C1 |
| MODULATION OF EXPRESSION OF CYTOKINES TH1/TH2 BY RIBAVIRIN AND RIBAVIRIN ANALOGS IN ACTIVATED T-LYMPHOCYTES | 1997 |
|
RU2186569C2 |
